Eugia US LLC recalls medroxyPROGESTERone Acetate Injectable Suspension
- Published
- 15 Jan 2025
- Units affected
- 19872 vials
- Agency
- FDA
- Country
- United States
The hazard
CGMP Deviations
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL, Rx only, 1 mL Single-Dose Vial, Mfd in India for: Eugia US LLC, NJ 08520 NDC 55150-329-01 Shipper label: medroxyPROGESTERone Acetate Injectable Suspension, USP, 150 mg per mL, Distributed by: Eugia US LLC, NJ, Manufactured by: Eugia Pharma Specialties Limited, India
- Brand / company
- Eugia US LLC
- Codes / lots
- Lot No.: 1MP24069, Exp.: 08/2026
- Distribution
- Nationwide in the US
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 15 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.